COVID-19 Antibody Research Begins In Texas
Austin, Texas resident John Doucette has twice received the experimental drug from Regeneron. Doucette is part of a year-long study working toward a COVID-19 vaccine.Wednesday, October 7th 2020, 8:47 am
By:
CBS News
Austin, Texas resident John Doucette has twice received the experimental drug from Regeneron. Doucette is part of a year-long study working toward a COVID-19 vaccine.
Get The Daily Update!
Be among the first to get breaking news, weather, and general news updates from News 9 delivered right to your inbox!
More Like This
October 7th, 2020
December 14th, 2021
June 1st, 2021
April 27th, 2021
Top Headlines
June 21st, 2025
June 21st, 2025